Global Anti-Aging Products and Therapies

Anti-Aging Products and Therapies Comprehensive Study by Type (Human Growth Hormone, Stem Cell, Placenta, Botulinum Toxin, Hyaluronic Acid), Application (Anti-Pigmentation Therapy, Anti-Cellulite Treatment, Anti-Wrinkle Treatment, Acne Management, Scar Treatment, Others), Active Ingredients (Retinol, Peptides, Argirelline), Distribution Channel (Dermatology Clinics, Hospitals, Pharmacies, Drug Stores, Rejuvenation Centers, Others.), Service (BOTOX, Proteomics, Gene Therapy, HRT, Dermal Fillers, Plastic Surgery) Players and Region - Global Market Outlook to 2028

Anti-Aging Products and Therapies Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Due to rise in aging populations in several developed and developing countries, the anti-aging products and therapies market will grow robustly over the forecasted period. In addition to this, the rising number of medical tourism for cosmetic procedures, as well as technological advancement in the field of anti-aging will further escalate the demand for anti-aging treatments and ultimately anti-aging products. Moreover, the growing adoption of minimally invasive anti-aging treatments and introduction to non-invasive laser treatments will attract global population. However, some of the severe side effects for the skin treatments might stagnate the demand for anti-aging products and treatments. Aging relates to maturing or growing old in terms of endurance, agility, strength, basal metabolism, speed of reaction, hearing acuity and many others. In case of geriatric population, the skin drier & less elastic; bones are comparatively brittle, and the teeth are shed.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia Pacific
UnitValue (USD Billion)
Key Companies ProfiledAllergan plc (Ireland), Ipsen (France), Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (China), Estee Lauder Companies Inc. (United States), Avon Products, Inc. (United Kingdom), Galderma S.A. (Switzerland), LG Life Sciences, Ltd. (South Korea), Bohus Biotech AB (Sweden), Imeik Technology Development Co Ltd (China), Merck & Co., Inc. (United States) and Gaoxin Zhangtong Co. Ltd. (China)


This growth is primarily driven by Increasing Geriatric Population across the Globe will boost the Demand and Rising Health Consciousness Among Consumers.

Globally, a noticeable market trend is evident Introduction to Highly Advanced Skin Treatments such as Neuromodulators For Tauter Skin The Diseases & Therapeutic Areas sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Allergan plc (Ireland), Ipsen (France), Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (China), Estee Lauder Companies Inc. (United States), Avon Products, Inc. (United Kingdom), Galderma S.A. (Switzerland), LG Life Sciences, Ltd. (South Korea), Bohus Biotech AB (Sweden), Imeik Technology Development Co Ltd (China), Merck & Co., Inc. (United States) and Gaoxin Zhangtong Co. Ltd. (China), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. Anti-Aging Products and Therapies market is a fragmented market due to the presence of various players. The players are focusing on increasing their manufacturing capacity. Further, companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

Key Developments in the Market:
In January 2019, a private equity firm, "Gryphon" has acquired RoC Skincare, This acquisition is beneficial in providing innovative products and complete skincare solution. It’s also useful for the company to expand its business portfolio in different regions.
On January 23, 2018, Estee Lauder introduced an Instant Wrinkle Filler Tri-Polymer Blend, which is beneficial in delivers filling spheres to decrease the look of fine lines and with repeated use, also helps the skin increase collagen production and promote cell turnover.

Regulatory Insights:
“According to Food and Drug Administration (FDA), it’s denoted that, cosmetics must be safe when consumers use them according to product labeling, or the way in which the products are customarily used. But the law does not require cosmetics to be approved by FDA before they go on the market. Drugs, however, must have FDA approval for both safety and effectiveness before they go on the market. Similarly, medical devices must go through FDA’s clearance process”.

Influencing Trend:
Introduction to Highly Advanced Skin Treatments such as Neuromodulators For Tauter Skin and Adoption of New Age Fillers like Hyaluronic acid and Calcium Hydroxyapatite Fillers

Market Growth Drivers:
Increasing Geriatric Population across the Globe will boost the Demand and Rising Health Consciousness Among Consumers

Challenges:
Stringent Government Regulations in Drug Development and Healthcare Industry

Restraints:
Significant Side-Effects of the Dermal Treatments for instance; Chemicals Available in Cosmetic Products are Found in Biopsies from Breast Tumors and Excessive Use might Disturb the Hormone Function of Consumer

Opportunities:
Growing Use of Botox injections and Ongoing Research and Developments in Developing Highly Advanced Treatments and Introduction to EmsculptTM From BTL Aesthetics which can tone Muscles in the Abdomen and Buttocks

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Anti-Aging Products and Therapies Market
- Analysis about New Entrants in Anti-Aging Products and Therapies Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Anti-Aging Products and Therapies Study Sheds Light on
— The Anti-Aging Products and Therapies Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Anti-Aging Products and Therapies industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Anti-Aging Products and Therapies industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Human Growth Hormone
  • Stem Cell
  • Placenta
  • Botulinum Toxin
  • Hyaluronic Acid
By Application
  • Anti-Pigmentation Therapy
  • Anti-Cellulite Treatment
  • Anti-Wrinkle Treatment
  • Acne Management
  • Scar Treatment
  • Others
By Active Ingredients
  • Retinol
  • Peptides
  • Argirelline

By Distribution Channel
  • Dermatology Clinics
  • Hospitals
  • Pharmacies
  • Drug Stores
  • Rejuvenation Centers
  • Others.

By Service
  • BOTOX
  • Proteomics
  • Gene Therapy
  • HRT
  • Dermal Fillers
  • Plastic Surgery

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Geriatric Population across the Globe will boost the Demand
      • 3.2.2. Rising Health Consciousness Among Consumers
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations in Drug Development and Healthcare Industry
    • 3.4. Market Trends
      • 3.4.1. Introduction to Highly Advanced Skin Treatments such as Neuromodulators For Tauter Skin
      • 3.4.2. Adoption of New Age Fillers like Hyaluronic acid and Calcium Hydroxyapatite Fillers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Anti-Aging Products and Therapies, by Type, Application, Active Ingredients, Distribution Channel, Service and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Anti-Aging Products and Therapies (Value)
      • 5.2.1. Global Anti-Aging Products and Therapies by: Type (Value)
        • 5.2.1.1. Human Growth Hormone
        • 5.2.1.2. Stem Cell
        • 5.2.1.3. Placenta
        • 5.2.1.4. Botulinum Toxin
        • 5.2.1.5. Hyaluronic Acid
      • 5.2.2. Global Anti-Aging Products and Therapies by: Application (Value)
        • 5.2.2.1. Anti-Pigmentation Therapy
        • 5.2.2.2. Anti-Cellulite Treatment
        • 5.2.2.3. Anti-Wrinkle Treatment
        • 5.2.2.4. Acne Management
        • 5.2.2.5. Scar Treatment
        • 5.2.2.6. Others
      • 5.2.3. Global Anti-Aging Products and Therapies by: Active Ingredients (Value)
        • 5.2.3.1. Retinol
        • 5.2.3.2. Peptides
        • 5.2.3.3. Argirelline
      • 5.2.4. Global Anti-Aging Products and Therapies by: Distribution Channel (Value)
        • 5.2.4.1. Dermatology Clinics
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Pharmacies
        • 5.2.4.4. Drug Stores
        • 5.2.4.5. Rejuvenation Centers
        • 5.2.4.6. Others.
      • 5.2.5. Global Anti-Aging Products and Therapies by: Service (Value)
        • 5.2.5.1. BOTOX
        • 5.2.5.2. Proteomics
        • 5.2.5.3. Gene Therapy
        • 5.2.5.4. HRT
        • 5.2.5.5. Dermal Fillers
        • 5.2.5.6. Plastic Surgery
      • 5.2.6. Global Anti-Aging Products and Therapies Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Anti-Aging Products and Therapies (Price)
      • 5.3.1. Global Anti-Aging Products and Therapies by: Type (Price)
  • 6. Anti-Aging Products and Therapies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ipsen (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Estee Lauder Companies Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Avon Products, Inc. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Galderma S.A. (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LG Life Sciences, Ltd. (South Korea)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bohus Biotech AB (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Imeik Technology Development Co Ltd (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck & Co., Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Gaoxin Zhangtong Co. Ltd. (China)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Anti-Aging Products and Therapies Sale, by Type, Application, Active Ingredients, Distribution Channel, Service and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Anti-Aging Products and Therapies (Value)
      • 7.2.1. Global Anti-Aging Products and Therapies by: Type (Value)
        • 7.2.1.1. Human Growth Hormone
        • 7.2.1.2. Stem Cell
        • 7.2.1.3. Placenta
        • 7.2.1.4. Botulinum Toxin
        • 7.2.1.5. Hyaluronic Acid
      • 7.2.2. Global Anti-Aging Products and Therapies by: Application (Value)
        • 7.2.2.1. Anti-Pigmentation Therapy
        • 7.2.2.2. Anti-Cellulite Treatment
        • 7.2.2.3. Anti-Wrinkle Treatment
        • 7.2.2.4. Acne Management
        • 7.2.2.5. Scar Treatment
        • 7.2.2.6. Others
      • 7.2.3. Global Anti-Aging Products and Therapies by: Active Ingredients (Value)
        • 7.2.3.1. Retinol
        • 7.2.3.2. Peptides
        • 7.2.3.3. Argirelline
      • 7.2.4. Global Anti-Aging Products and Therapies by: Distribution Channel (Value)
        • 7.2.4.1. Dermatology Clinics
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Pharmacies
        • 7.2.4.4. Drug Stores
        • 7.2.4.5. Rejuvenation Centers
        • 7.2.4.6. Others.
      • 7.2.5. Global Anti-Aging Products and Therapies by: Service (Value)
        • 7.2.5.1. BOTOX
        • 7.2.5.2. Proteomics
        • 7.2.5.3. Gene Therapy
        • 7.2.5.4. HRT
        • 7.2.5.5. Dermal Fillers
        • 7.2.5.6. Plastic Surgery
      • 7.2.6. Global Anti-Aging Products and Therapies Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Anti-Aging Products and Therapies (Price)
      • 7.3.1. Global Anti-Aging Products and Therapies by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Anti-Aging Products and Therapies: by Type(USD Billion)
  • Table 2. Anti-Aging Products and Therapies Human Growth Hormone , by Region USD Billion (2017-2022)
  • Table 3. Anti-Aging Products and Therapies Stem Cell , by Region USD Billion (2017-2022)
  • Table 4. Anti-Aging Products and Therapies Placenta , by Region USD Billion (2017-2022)
  • Table 5. Anti-Aging Products and Therapies Botulinum Toxin , by Region USD Billion (2017-2022)
  • Table 6. Anti-Aging Products and Therapies Hyaluronic Acid , by Region USD Billion (2017-2022)
  • Table 7. Anti-Aging Products and Therapies: by Application(USD Billion)
  • Table 8. Anti-Aging Products and Therapies Anti-Pigmentation Therapy , by Region USD Billion (2017-2022)
  • Table 9. Anti-Aging Products and Therapies Anti-Cellulite Treatment , by Region USD Billion (2017-2022)
  • Table 10. Anti-Aging Products and Therapies Anti-Wrinkle Treatment , by Region USD Billion (2017-2022)
  • Table 11. Anti-Aging Products and Therapies Acne Management , by Region USD Billion (2017-2022)
  • Table 12. Anti-Aging Products and Therapies Scar Treatment , by Region USD Billion (2017-2022)
  • Table 13. Anti-Aging Products and Therapies Others , by Region USD Billion (2017-2022)
  • Table 14. Anti-Aging Products and Therapies: by Active Ingredients(USD Billion)
  • Table 15. Anti-Aging Products and Therapies Retinol , by Region USD Billion (2017-2022)
  • Table 16. Anti-Aging Products and Therapies Peptides , by Region USD Billion (2017-2022)
  • Table 17. Anti-Aging Products and Therapies Argirelline , by Region USD Billion (2017-2022)
  • Table 18. Anti-Aging Products and Therapies: by Distribution Channel(USD Billion)
  • Table 19. Anti-Aging Products and Therapies Dermatology Clinics , by Region USD Billion (2017-2022)
  • Table 20. Anti-Aging Products and Therapies Hospitals , by Region USD Billion (2017-2022)
  • Table 21. Anti-Aging Products and Therapies Pharmacies , by Region USD Billion (2017-2022)
  • Table 22. Anti-Aging Products and Therapies Drug Stores , by Region USD Billion (2017-2022)
  • Table 23. Anti-Aging Products and Therapies Rejuvenation Centers , by Region USD Billion (2017-2022)
  • Table 24. Anti-Aging Products and Therapies Others. , by Region USD Billion (2017-2022)
  • Table 25. Anti-Aging Products and Therapies: by Service(USD Billion)
  • Table 26. Anti-Aging Products and Therapies BOTOX , by Region USD Billion (2017-2022)
  • Table 27. Anti-Aging Products and Therapies Proteomics , by Region USD Billion (2017-2022)
  • Table 28. Anti-Aging Products and Therapies Gene Therapy , by Region USD Billion (2017-2022)
  • Table 29. Anti-Aging Products and Therapies HRT , by Region USD Billion (2017-2022)
  • Table 30. Anti-Aging Products and Therapies Dermal Fillers , by Region USD Billion (2017-2022)
  • Table 31. Anti-Aging Products and Therapies Plastic Surgery , by Region USD Billion (2017-2022)
  • Table 32. South America Anti-Aging Products and Therapies, by Country USD Billion (2017-2022)
  • Table 33. South America Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 34. South America Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 35. South America Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 36. South America Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 37. South America Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 38. Brazil Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 39. Brazil Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 40. Brazil Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 41. Brazil Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 42. Brazil Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 43. Argentina Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 44. Argentina Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 45. Argentina Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 46. Argentina Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 47. Argentina Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 48. Rest of South America Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 49. Rest of South America Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 50. Rest of South America Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 51. Rest of South America Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 52. Rest of South America Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 53. Asia Pacific Anti-Aging Products and Therapies, by Country USD Billion (2017-2022)
  • Table 54. Asia Pacific Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 55. Asia Pacific Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 56. Asia Pacific Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 57. Asia Pacific Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 58. Asia Pacific Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 59. China Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 60. China Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 61. China Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 62. China Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 63. China Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 64. Japan Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 65. Japan Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 66. Japan Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 67. Japan Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 68. Japan Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 69. India Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 70. India Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 71. India Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 72. India Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 73. India Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 74. South Korea Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 75. South Korea Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 76. South Korea Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 77. South Korea Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 78. South Korea Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 79. Taiwan Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 80. Taiwan Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 81. Taiwan Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 82. Taiwan Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 83. Taiwan Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 84. Australia Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 85. Australia Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 86. Australia Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 87. Australia Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 88. Australia Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 89. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 90. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 91. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 92. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 93. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 94. Europe Anti-Aging Products and Therapies, by Country USD Billion (2017-2022)
  • Table 95. Europe Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 96. Europe Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 97. Europe Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 98. Europe Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 99. Europe Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 100. Germany Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 101. Germany Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 102. Germany Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 103. Germany Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 104. Germany Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 105. France Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 106. France Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 107. France Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 108. France Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 109. France Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 110. Italy Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 111. Italy Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 112. Italy Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 113. Italy Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 114. Italy Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 115. United Kingdom Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 116. United Kingdom Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 117. United Kingdom Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 118. United Kingdom Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 119. United Kingdom Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 120. Netherlands Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 121. Netherlands Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 122. Netherlands Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 123. Netherlands Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 124. Netherlands Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 125. Rest of Europe Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 126. Rest of Europe Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 127. Rest of Europe Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 128. Rest of Europe Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 129. Rest of Europe Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 130. MEA Anti-Aging Products and Therapies, by Country USD Billion (2017-2022)
  • Table 131. MEA Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 132. MEA Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 133. MEA Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 134. MEA Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 135. MEA Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 136. Middle East Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 137. Middle East Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 138. Middle East Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 139. Middle East Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 140. Middle East Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 141. Africa Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 142. Africa Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 143. Africa Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 144. Africa Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 145. Africa Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 146. North America Anti-Aging Products and Therapies, by Country USD Billion (2017-2022)
  • Table 147. North America Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 148. North America Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 149. North America Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 150. North America Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 151. North America Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 152. United States Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 153. United States Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 154. United States Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 155. United States Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 156. United States Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 157. Canada Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 158. Canada Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 159. Canada Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 160. Canada Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 161. Canada Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 162. Mexico Anti-Aging Products and Therapies, by Type USD Billion (2017-2022)
  • Table 163. Mexico Anti-Aging Products and Therapies, by Application USD Billion (2017-2022)
  • Table 164. Mexico Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2017-2022)
  • Table 165. Mexico Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2017-2022)
  • Table 166. Mexico Anti-Aging Products and Therapies, by Service USD Billion (2017-2022)
  • Table 167. Anti-Aging Products and Therapies: by Type(USD/Units)
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Company Basic Information, Sales Area and Its Competitors
  • Table 174. Company Basic Information, Sales Area and Its Competitors
  • Table 175. Company Basic Information, Sales Area and Its Competitors
  • Table 176. Company Basic Information, Sales Area and Its Competitors
  • Table 177. Company Basic Information, Sales Area and Its Competitors
  • Table 178. Company Basic Information, Sales Area and Its Competitors
  • Table 179. Anti-Aging Products and Therapies: by Type(USD Billion)
  • Table 180. Anti-Aging Products and Therapies Human Growth Hormone , by Region USD Billion (2023-2028)
  • Table 181. Anti-Aging Products and Therapies Stem Cell , by Region USD Billion (2023-2028)
  • Table 182. Anti-Aging Products and Therapies Placenta , by Region USD Billion (2023-2028)
  • Table 183. Anti-Aging Products and Therapies Botulinum Toxin , by Region USD Billion (2023-2028)
  • Table 184. Anti-Aging Products and Therapies Hyaluronic Acid , by Region USD Billion (2023-2028)
  • Table 185. Anti-Aging Products and Therapies: by Application(USD Billion)
  • Table 186. Anti-Aging Products and Therapies Anti-Pigmentation Therapy , by Region USD Billion (2023-2028)
  • Table 187. Anti-Aging Products and Therapies Anti-Cellulite Treatment , by Region USD Billion (2023-2028)
  • Table 188. Anti-Aging Products and Therapies Anti-Wrinkle Treatment , by Region USD Billion (2023-2028)
  • Table 189. Anti-Aging Products and Therapies Acne Management , by Region USD Billion (2023-2028)
  • Table 190. Anti-Aging Products and Therapies Scar Treatment , by Region USD Billion (2023-2028)
  • Table 191. Anti-Aging Products and Therapies Others , by Region USD Billion (2023-2028)
  • Table 192. Anti-Aging Products and Therapies: by Active Ingredients(USD Billion)
  • Table 193. Anti-Aging Products and Therapies Retinol , by Region USD Billion (2023-2028)
  • Table 194. Anti-Aging Products and Therapies Peptides , by Region USD Billion (2023-2028)
  • Table 195. Anti-Aging Products and Therapies Argirelline , by Region USD Billion (2023-2028)
  • Table 196. Anti-Aging Products and Therapies: by Distribution Channel(USD Billion)
  • Table 197. Anti-Aging Products and Therapies Dermatology Clinics , by Region USD Billion (2023-2028)
  • Table 198. Anti-Aging Products and Therapies Hospitals , by Region USD Billion (2023-2028)
  • Table 199. Anti-Aging Products and Therapies Pharmacies , by Region USD Billion (2023-2028)
  • Table 200. Anti-Aging Products and Therapies Drug Stores , by Region USD Billion (2023-2028)
  • Table 201. Anti-Aging Products and Therapies Rejuvenation Centers , by Region USD Billion (2023-2028)
  • Table 202. Anti-Aging Products and Therapies Others. , by Region USD Billion (2023-2028)
  • Table 203. Anti-Aging Products and Therapies: by Service(USD Billion)
  • Table 204. Anti-Aging Products and Therapies BOTOX , by Region USD Billion (2023-2028)
  • Table 205. Anti-Aging Products and Therapies Proteomics , by Region USD Billion (2023-2028)
  • Table 206. Anti-Aging Products and Therapies Gene Therapy , by Region USD Billion (2023-2028)
  • Table 207. Anti-Aging Products and Therapies HRT , by Region USD Billion (2023-2028)
  • Table 208. Anti-Aging Products and Therapies Dermal Fillers , by Region USD Billion (2023-2028)
  • Table 209. Anti-Aging Products and Therapies Plastic Surgery , by Region USD Billion (2023-2028)
  • Table 210. South America Anti-Aging Products and Therapies, by Country USD Billion (2023-2028)
  • Table 211. South America Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 212. South America Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 213. South America Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 214. South America Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 215. South America Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 216. Brazil Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 217. Brazil Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 218. Brazil Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 219. Brazil Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 220. Brazil Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 221. Argentina Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 222. Argentina Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 223. Argentina Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 224. Argentina Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 225. Argentina Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 226. Rest of South America Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 227. Rest of South America Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 228. Rest of South America Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 229. Rest of South America Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 230. Rest of South America Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 231. Asia Pacific Anti-Aging Products and Therapies, by Country USD Billion (2023-2028)
  • Table 232. Asia Pacific Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 233. Asia Pacific Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 234. Asia Pacific Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 235. Asia Pacific Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 236. Asia Pacific Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 237. China Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 238. China Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 239. China Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 240. China Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 241. China Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 242. Japan Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 243. Japan Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 244. Japan Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 245. Japan Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 246. Japan Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 247. India Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 248. India Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 249. India Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 250. India Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 251. India Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 252. South Korea Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 253. South Korea Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 254. South Korea Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 255. South Korea Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 256. South Korea Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 257. Taiwan Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 258. Taiwan Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 259. Taiwan Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 260. Taiwan Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 261. Taiwan Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 262. Australia Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 263. Australia Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 264. Australia Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 265. Australia Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 266. Australia Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 267. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 268. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 269. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 270. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 271. Rest of Asia-Pacific Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 272. Europe Anti-Aging Products and Therapies, by Country USD Billion (2023-2028)
  • Table 273. Europe Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 274. Europe Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 275. Europe Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 276. Europe Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 277. Europe Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 278. Germany Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 279. Germany Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 280. Germany Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 281. Germany Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 282. Germany Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 283. France Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 284. France Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 285. France Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 286. France Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 287. France Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 288. Italy Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 289. Italy Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 290. Italy Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 291. Italy Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 292. Italy Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 293. United Kingdom Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 294. United Kingdom Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 295. United Kingdom Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 296. United Kingdom Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 297. United Kingdom Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 298. Netherlands Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 299. Netherlands Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 300. Netherlands Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 301. Netherlands Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 302. Netherlands Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 303. Rest of Europe Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 304. Rest of Europe Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 305. Rest of Europe Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 306. Rest of Europe Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 307. Rest of Europe Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 308. MEA Anti-Aging Products and Therapies, by Country USD Billion (2023-2028)
  • Table 309. MEA Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 310. MEA Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 311. MEA Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 312. MEA Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 313. MEA Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 314. Middle East Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 315. Middle East Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 316. Middle East Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 317. Middle East Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 318. Middle East Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 319. Africa Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 320. Africa Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 321. Africa Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 322. Africa Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 323. Africa Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 324. North America Anti-Aging Products and Therapies, by Country USD Billion (2023-2028)
  • Table 325. North America Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 326. North America Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 327. North America Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 328. North America Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 329. North America Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 330. United States Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 331. United States Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 332. United States Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 333. United States Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 334. United States Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 335. Canada Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 336. Canada Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 337. Canada Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 338. Canada Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 339. Canada Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 340. Mexico Anti-Aging Products and Therapies, by Type USD Billion (2023-2028)
  • Table 341. Mexico Anti-Aging Products and Therapies, by Application USD Billion (2023-2028)
  • Table 342. Mexico Anti-Aging Products and Therapies, by Active Ingredients USD Billion (2023-2028)
  • Table 343. Mexico Anti-Aging Products and Therapies, by Distribution Channel USD Billion (2023-2028)
  • Table 344. Mexico Anti-Aging Products and Therapies, by Service USD Billion (2023-2028)
  • Table 345. Anti-Aging Products and Therapies: by Type(USD/Units)
  • Table 346. Research Programs/Design for This Report
  • Table 347. Key Data Information from Secondary Sources
  • Table 348. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Anti-Aging Products and Therapies: by Type USD Billion (2017-2022)
  • Figure 5. Global Anti-Aging Products and Therapies: by Application USD Billion (2017-2022)
  • Figure 6. Global Anti-Aging Products and Therapies: by Active Ingredients USD Billion (2017-2022)
  • Figure 7. Global Anti-Aging Products and Therapies: by Distribution Channel USD Billion (2017-2022)
  • Figure 8. Global Anti-Aging Products and Therapies: by Service USD Billion (2017-2022)
  • Figure 9. South America Anti-Aging Products and Therapies Share (%), by Country
  • Figure 10. Asia Pacific Anti-Aging Products and Therapies Share (%), by Country
  • Figure 11. Europe Anti-Aging Products and Therapies Share (%), by Country
  • Figure 12. MEA Anti-Aging Products and Therapies Share (%), by Country
  • Figure 13. North America Anti-Aging Products and Therapies Share (%), by Country
  • Figure 14. Global Anti-Aging Products and Therapies: by Type USD/Units (2017-2022)
  • Figure 15. Global Anti-Aging Products and Therapies share by Players 2022 (%)
  • Figure 16. Global Anti-Aging Products and Therapies share by Players (Top 3) 2022(%)
  • Figure 17. Global Anti-Aging Products and Therapies share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Allergan plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Allergan plc (Ireland) Revenue: by Geography 2022
  • Figure 21. Ipsen (France) Revenue, Net Income and Gross profit
  • Figure 22. Ipsen (France) Revenue: by Geography 2022
  • Figure 23. Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (China) Revenue, Net Income and Gross profit
  • Figure 24. Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (China) Revenue: by Geography 2022
  • Figure 25. Estee Lauder Companies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Estee Lauder Companies Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Avon Products, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Avon Products, Inc. (United Kingdom) Revenue: by Geography 2022
  • Figure 29. Galderma S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Galderma S.A. (Switzerland) Revenue: by Geography 2022
  • Figure 31. LG Life Sciences, Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 32. LG Life Sciences, Ltd. (South Korea) Revenue: by Geography 2022
  • Figure 33. Bohus Biotech AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 34. Bohus Biotech AB (Sweden) Revenue: by Geography 2022
  • Figure 35. Imeik Technology Development Co Ltd (China) Revenue, Net Income and Gross profit
  • Figure 36. Imeik Technology Development Co Ltd (China) Revenue: by Geography 2022
  • Figure 37. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Merck & Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 39. Gaoxin Zhangtong Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 40. Gaoxin Zhangtong Co. Ltd. (China) Revenue: by Geography 2022
  • Figure 41. Global Anti-Aging Products and Therapies: by Type USD Billion (2023-2028)
  • Figure 42. Global Anti-Aging Products and Therapies: by Application USD Billion (2023-2028)
  • Figure 43. Global Anti-Aging Products and Therapies: by Active Ingredients USD Billion (2023-2028)
  • Figure 44. Global Anti-Aging Products and Therapies: by Distribution Channel USD Billion (2023-2028)
  • Figure 45. Global Anti-Aging Products and Therapies: by Service USD Billion (2023-2028)
  • Figure 46. South America Anti-Aging Products and Therapies Share (%), by Country
  • Figure 47. Asia Pacific Anti-Aging Products and Therapies Share (%), by Country
  • Figure 48. Europe Anti-Aging Products and Therapies Share (%), by Country
  • Figure 49. MEA Anti-Aging Products and Therapies Share (%), by Country
  • Figure 50. North America Anti-Aging Products and Therapies Share (%), by Country
  • Figure 51. Global Anti-Aging Products and Therapies: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Allergan plc (Ireland)
  • Ipsen (France)
  • Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (China)
  • Estee Lauder Companies Inc. (United States)
  • Avon Products, Inc. (United Kingdom)
  • Galderma S.A. (Switzerland)
  • LG Life Sciences, Ltd. (South Korea)
  • Bohus Biotech AB (Sweden)
  • Imeik Technology Development Co Ltd (China)
  • Merck & Co., Inc. (United States)
  • Gaoxin Zhangtong Co. Ltd. (China)
Additional players considered in the study are as follows:
Beiersdorf AG (Germany) , BioPharma US Corp (United States)
Select User Access Type

Key Highlights of Report


May 2023 234 Pages 77 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Anti-Aging Products and Therapies Quantitative research analysis
Global Anti-Aging Products and Therapies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Anti-Aging Products and Therapies market are Allergan plc (Ireland), Ipsen (France), Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (China), Estee Lauder Companies Inc. (United States), Avon Products, Inc. (United Kingdom), Galderma S.A. (Switzerland), LG Life Sciences, Ltd. (South Korea), Bohus Biotech AB (Sweden), Imeik Technology Development Co Ltd (China), Merck & Co., Inc. (United States) and Gaoxin Zhangtong Co. Ltd. (China), to name a few.
North America is dominating the Anti-Aging Products and Therapies Market.
"Stringent Government Regulations in Drug Development and Healthcare Industry" is seen as one of the major challenges by many Industry Players of Anti-Aging Products and Therapies Market
The Anti-Aging Products and Therapies market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Anti-Aging Products and Therapies market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Anti-Aging Products and Therapies Report?

Have a Query? Click Here

Other Related Reports

Duchenne Muscular Dystrophy Comprehensive Study by Type (Duchenne/Becker (DMD/BMD), Myotonic (DM), Limb-Girdle (LGMD), Facioscapulohumeral (FSHD), Congenital (CMD), Oculopharyngeal (OPMD), Emery-Drei...
$ 3650
Diabetic Neuropathy Comprehensive Study by Type (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), Application (Hospitals, Clinics, Retail Pharmacy, Online Pharmacy...
$ 3750
Donepezil Comprehensive Study by Type (5mg, 10mg, 23mg), Application (Hospitals, Clinics, Drugstore), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2027
$ 3500
Leukemia Therapeutics Comprehensive Study by Type (Chemotherapy, Biological Therapy, Radiation therapy, Targeted therapy), Application (Hospital, Clinic), Mode of Administration (Oral, Injectable), M...
$ 3750
Age Related Macular Degeneration Comprehensive Study by Type (Wet AMD, Dry AMD), Drugs (Lucentis, Eylea, Avastin, Others), Route of Administration (Intravenous, Intravitreal) Players and Region - Glo...
$ 3500
Diabetic Nephropathy Comprehensive Study by Application (Hospitals, Cancer Research Institutes, Diagnostic Labs), Treatment (Medication, Kidney Dialysis, Kidney Transplant), Stages (Microalbuminuria ...
$ 3750